Passage of Federal Right-to-Try law poses risks and opportunities for patients and the biopharmaceutical industry
In an example of life imitating art, several states are considering “right-to-try” legislation to make experimental drugs—drugs that don’t have FDA approval—available to the terminally ill. Colorado and Louisiana have...more